Akso HealthvsBroadcom

AHG and AVGO stock compared: price, dividend, valuation and results, from SEC filings.

AHG

Akso Health Group

$1.24

Value $896M

-3.13%
AHG's page

AVGO

Broadcom Inc.

$304.30

Value $1.44T

-12.15%
AVGO's page

Akso Health (AHG) has a market value of $896M and Broadcom (AVGO) $1.44T. Over the last year, with dividends, AHG moved -19.0% and AVGO -13.3%. Dividend yield: AHG none, AVGO 0.85%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AHG$896M

    AVGO$1.44T

    AVGO is 1,610 times AHG

  • Revenue, 12 months

    AHG$14M

    AVGO$89.1B

    AVGO is 6,442 times AHG

  • Net income, 12 months

    AHG-$19M

    AVGO$38.3B

  • Operating margin

    AHG-149.7%

    AVGO48.1%

    197.8 points apart

  • ROIC

    AHG-9.0%

    AVGO27.3%

    36.3 points apart

  • P/E

    AHG–

    AVGO37.7

  • Dividend yield

    AHG0.0%

    AVGO0.9%

    0.9 points apart

  • 5-year return

    AHG-57.7%

    AVGO+485.7%

    543.4 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AHG-57.7%

AVGO+485.8%

025050075020222023202420252026
Returns by period
PeriodAHGWith dividendsAVGOWith dividends
1 year since November 19, 2025-19.0%Price -19.0%-13.3%Price -14.0%
3 years since November 20, 2023+10.7%+3.5% a yearPrice +10.7%+216.3%+46.8% a yearPrice +206.2%
5 years since November 19, 2021-57.7%-15.8% a yearPrice -57.7%+485.7%+42.4% a yearPrice +436.2%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AHGAkso HealthAVGOBroadcom

Valuation

AHGAVGO
Valuation
Price$1.24$304.30
Market value$896M$1.44T
Enterprise value (EV)$896M$1.48T
P/E–37.7
P/E, 5-year median–30.4
P/B5.014.5
EV/EBIT–34.5
Free cash flow yield–2.7%

Results and growth

AHGAVGO
Results and growth
Revenue, 12 months$14M$89.1B
Net income, 12 months-$19M$38.3B
Free cash flow, 12 months-$13M$39.4B
Earnings per share, 12 months$0.03$7.84
Revenue growth, year on year-6.4%23.9%
Revenue growth a year, past+51.1%over 5 years+21.7%over 5 years
EPS growth a year, past–+49.8%over 5 years

Margins and returns on capital

AHGAVGO
Margins and returns on capital
Gross margin-0.1%68.8%
Operating margin-149.7%48.1%
Net margin-135.0%42.9%
ROIC-9.0%27.3%
ROE-10.3%45.4%

Balance sheet

AHGAVGO
Balance sheet
Cash$170.6K$24.0B
Total debt$25.1K$59.4B
Net debt / EBITDA–0.8
Interest cover–13.7×

Dividends and buybacks

AHGAVGO
Dividends and buybacks
Dividend yield–0.9%
Dividend per share, 12 months–$2.60
Dividend growth a year, past–+12.7%over 5 years
Buyback yield–0.2%
Shareholder yield–1.0%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AHG or AVGO

Didn't find what you were looking for?

Ask us
Which is bigger, Akso Health or Broadcom?

By market value, Broadcom ($1.44T) is about 1,610.0 times Akso Health ($896M), at today's prices.

How did AHG and AVGO stock do over the last 5 years?

Since November 19, 2021, AHG's price moved -57.7% and AVGO's +436.2%. With dividends: AHG -57.7% (-15.8% a year), AVGO +485.7% (+42.4% a year). Past returns do not predict future ones.

Which pays the higher dividend, AHG or AVGO?

The dividend yield at today's price is none for Akso Health and 0.85% for Broadcom. Over the last twelve months they paid – and $2.60 per share.

Which has the higher profit margins, Akso Health or Broadcom?

Over the last twelve months, the net margin was -135.0% for Akso Health and 42.9% for Broadcom, and the operating margin -149.7% and 48.1%. Revenue was $14M and $89.1B.

Which is the better investment, Akso Health or Broadcom?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.